QA: AILERON THERAPEUTICS INC in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001420565_2021_AILERON_THERAPEUTICS_INC.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001420565')"}

Graph

Absolute values for 0001420565, AILERON THERAPEUTICS INC

  xvar xval
0 AssetsCurrent 16,326,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 15,000
3 remainder_Assets 0
4 LiabilitiesCurrent 3,960,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 219,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 9,330,000
9 ResearchAndDevelopmentExpense 11,166,000
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome -661,000
13 remainder_ComprehensiveNetIncome -9,000
  yvar yval
0 Assets 16,341,000
1 Liabilities 4,179,000
2 Expenses 20,496,000
3 Revenues 0
4 StockholdersEquity 12,162,000
5 NetIncome -21,157,000
6 ComprehensiveNetIncome -21,161,500
7 BaseVar 20,843,000
8 EconomicCapitalRatio -0.0237

Edgar->Model Mapping

Feature Distribution

Change over Time